Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)

Celine Busard; Stef Menting; Sun-Jine van Bezooijen; Juul van den Reek; Barbara Hutten; Errol Prens; Elke de Jong; Martijn van Doorn; Phyllis Spuls

doi:https://doi.org/10.1186/s13063-017-1848-0

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)

Celine Busard, Stef Menting, Sun-Jine van Bezooijen, Juul van den Reek, Barbara Hutten, Errol Prens, Elke de Jong, Martijn van Doorn, Phyllis Spuls

Research output: Contribution to journal › Comment/Letter to the editor › Academic

3 Citations (Scopus)

Original language	English
Pages (from-to)	113
Journal	Trials
Volume	18
Issue number	1
DOIs	https://doi.org/10.1186/s13063-017-1848-0
Publication status	Published - 2017

Access to Document

https://doi.org/10.1186/s13063-017-1848-0

Cite this

Busard, C., Menting, S., van Bezooijen, S.-J., van den Reek, J., Hutten, B., Prens, E., de Jong, E., van Doorn, M., & Spuls, P. (2017). Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017). Trials, 18(1), 113. https://doi.org/10.1186/s13063-017-1848-0

@article{9510fcab922a46419a0c939bbd259550,

title = "Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)",

author = "Celine Busard and Stef Menting and {van Bezooijen}, Sun-Jine and {van den Reek}, Juul and Barbara Hutten and Errol Prens and {de Jong}, Elke and {van Doorn}, Martijn and Phyllis Spuls",

year = "2017",

doi = "https://doi.org/10.1186/s13063-017-1848-0",

language = "English",

volume = "18",

pages = "113",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central",

number = "1",

}

Busard, C, Menting, S, van Bezooijen, S-J, van den Reek, J, Hutten, B, Prens, E, de Jong, E, van Doorn, M & Spuls, P 2017, 'Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)', Trials, vol. 18, no. 1, pp. 113. https://doi.org/10.1186/s13063-017-1848-0

Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017). / Busard, Celine; Menting, Stef; van Bezooijen, Sun-Jine et al.
In: Trials, Vol. 18, No. 1, 2017, p. 113.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial (vol 18, 52, 2017)

AU - Busard, Celine

AU - Menting, Stef

AU - van Bezooijen, Sun-Jine

AU - van den Reek, Juul

AU - Hutten, Barbara

AU - Prens, Errol

AU - de Jong, Elke

AU - van Doorn, Martijn

AU - Spuls, Phyllis

PY - 2017

Y1 - 2017

U2 - https://doi.org/10.1186/s13063-017-1848-0

DO - https://doi.org/10.1186/s13063-017-1848-0

M3 - Comment/Letter to the editor

C2 - 28270175

SN - 1745-6215

VL - 18

SP - 113

JO - Trials

JF - Trials

IS - 1

ER -